Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV
Kaneka has unveiled KANEKA KanCapA, a new protein A chromatography resin to purify therapeutic antibodies. Protein A chromatography resin is widely used to produce antibodies due to its high affinity and excellent selectivity for ...
Magellan Pharmacy Solutions has launched Total Drug Solutions, an integrated approach to manage oral, injectable and infusible drugs to improve the quality and safety of care while lowering costs for consumers and health plans. Magellan ...
Tags: Magellan Pharmacy Solutions, total drug solutions, integrated approach
Saladax Biomedical has received CE mark for its MyPaclitaxel and MyDocetaxel therapeutic dose management (TDM) MyCare assays, enabling commercialisation in the European Union (EU). Both paclitaxel and docetaxel are administered based on a ...
Tags: Saladax Biomedical, Saladax's MyCare technology platform, MyCare tests
EvaluatePharma has unveiled a new service enhancement, Tracking Drugs@FDA, which provides clients access to the entire approved FDA drugs, related FDA document library and FDA Orange Book patent data. Tracking Drugs@FDA and Orange Book ...
Tags: EvaluatePharma, Tracking Drugs@FDA, ANDA
Relay Technology Management (Relay TM) has introduced Business Development Live (BD Live!), a new unified, real-time data visualization, comparative asset analysis and tracking platform for the life sciences industry. BD Live! enables ...
Tags: Relay TM, Relay Technology Management, real-time data visualization
Brightly lit hospitals and clinics can be disorientating spaces for the elderly and infirm. Peter Stuart looks at how research into wellbeing and visual perception is changing the face of lighting in healthcare environments. ...
Tags: Brightly lit hospitals and clinics, healthcare environments
Janssen Research & Development company has submitted bedaquiline (TMC207) new drug application (NDA) to the US Food and Drug Administration (FDA) for approval. Bedaquiline,an investigational drug administered orally,is used as part of ...
Tags: FDA, new drug application, investigational drug, pulmonary
BioTime and its wholly owned subsidiary, LifeMap Sciences, have announced an agreement to purchase XenneX. The acquisition, which is expected to close within 30 days, will merge XenneX into LifeMap Sciences. The deal is expected to ...
Tags: BioTime, XenneX, LifeMap Sciences
Takeda America Holdings, a wholly owned subsidiary of Takeda Pharmaceutical Company, has acquired URL Pharma for an upfront payment of $800m. Takeda will begin the integration of URL Pharma and will right away assume responsibility for ...
Valeant Pharmaceuticals has signed an agreement to obtain certain assets from Atlantis Pharma, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71m. The transaction is expected ...
Tags: Valeant Pharmaceuticals, analgesics, anti-inflammatory therapeutic
Theravectys has received regulatory clearances from France's National Security Agency and Belgium's Federal Agency for Medicines and Health Products to commence a phase I/II clinical trial of its anti-HIV therapeutic vaccine. Using the ...
Tags: Theravectys, HIV positive patients, anti-HIV therapeutic vaccine
Stiefel, a GSK company, has acquired the development and commercialization rights to Welichem Biotech (WBI) anti-inflammatory agent, WBI-1001. The acquisition follows the previously announced asset purchase agreement. WBI-1001 ...
Tags: acquisition, clinical drugs, Stiefel
Saladax Biomedical has signed a distribution contract with INyDIA Labs for My5-FU, a test that measures levels of 5-fluorouracil (5-FU), in the blood of cancer patients, in Spain and Protugal. INyDIA will provide My5-FU test kits to ...
Tags: medical research, medical test, clinical research, company collaboration
Saladax Biomedical has signed a diagnostic agreement with Eilaf Pharma for My5-FU diagnostic test in Egypt and throughout the Middle East North African (MENA) region. The test will measure the levels of an anti-cancer drug, ...
Tags: My5-FU diagnostic test, medical research, medical test